Fig. 5From: The correlation between HTA recommendations and reimbursement status of orphan drugs in EuropeShare (%) of orphan drugs that have never been assessed by any of the HTA Agency considered that are reimbursed, by country. Source: Authors based on information from the websites of the eight HTA agencies. Note: Countries with special criteria for orphan drugs in the reimbursement decision process are marked in blackBack to article page